TP53 and neoplasm: Of note, TP53 mutations found in 2 PAX8/NGS concordant cases, for which we had matched tumor and non-neoplastic material available (P19 and P20), were also found to be tumor specific (Supplementary Figure 2A; Supplementary Table 2), adding robustness to the NGS approach.